These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23365707)

  • 1. Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: diagnosis and treatment.
    DeSalvo MN
    J Radiol Case Rep; 2012 Jul; 6(7):9-16. PubMed ID: 23365707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab reverses cerebral radiation necrosis.
    Wong ET; Huberman M; Lu XQ; Mahadevan A
    J Clin Oncol; 2008 Dec; 26(34):5649-50. PubMed ID: 18981459
    [No Abstract]   [Full Text] [Related]  

  • 3. Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study.
    Boström JP; Seifert M; Greschus S; Schäfer N; Glas M; Lammering G; Herrlinger U
    Strahlenther Onkol; 2014 Apr; 190(4):416-21. PubMed ID: 24429478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management.
    Chen J; Dassarath M; Yin Z; Liu H; Yang K; Wu G
    Radiat Oncol; 2011 Sep; 6():128. PubMed ID: 21961805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
    Furuse M; Kawabata S; Kuroiwa T; Miyatake S
    J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
    Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
    Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
    Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
    J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
    Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
    J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis.
    Benoit A; Ducray F; Cartalat-Carel S; Psimaras D; Ricard D; Honnorat J
    J Neurol; 2011 Feb; 258(2):328-9. PubMed ID: 20862487
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal bevacizumab for radiation-induced cystoid macular oedema in patients with nasopharyngeal carcinoma: a clinical series.
    Subrayan V; Khaw KW; Peyman M; Koay AC; Tajunisah I
    Ophthalmologica; 2013; 229(4):208-11. PubMed ID: 23548379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
    Lubelski D; Abdullah KG; Weil RJ; Marko NF
    J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation retinopathy after external beam irradiation for nasopharyngeal carcinoma: A case report and review of the literature.
    Bawankar P; Barman M; Bhattacharjee H; Soibam R; Paulbuddhe V
    Pract Radiat Oncol; 2018; 8(6):366-368. PubMed ID: 29861351
    [No Abstract]   [Full Text] [Related]  

  • 14. Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.
    Lee NY; Zhang Q; Pfister DG; Kim J; Garden AS; Mechalakos J; Hu K; Le QT; Colevas AD; Glisson BS; Chan AT; Ang KK
    Lancet Oncol; 2012 Feb; 13(2):172-80. PubMed ID: 22178121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.
    Torcuator R; Zuniga R; Mohan YS; Rock J; Doyle T; Anderson J; Gutierrez J; Ryu S; Jain R; Rosenblum M; Mikkelsen T
    J Neurooncol; 2009 Aug; 94(1):63-8. PubMed ID: 19189055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings.
    Chong VF; Rumpel H; Fan YF; Mukherji SK
    Eur Radiol; 2001; 11(2):317-24. PubMed ID: 11218034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
    Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study.
    Artzi M; Bokstein F; Blumenthal DT; Aizenstein O; Liberman G; Corn BW; Ben Bashat D
    Eur J Radiol; 2014 Jul; 83(7):1250-1256. PubMed ID: 24809637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
    Liu AK; Macy ME; Foreman NK
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1148-54. PubMed ID: 19857784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
    Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
    Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.